Journal: Translational Cancer Research
Article Title: Silencing PPA1 promotes the survival of non-small cell lung cancer A549 cells under glucose-starved conditions
doi: 10.21037/tcr-2025-1106
Figure Lengend Snippet: Silencing PPA1 enhances A549 survival under glucose-free condition. (A) CCK-8 detection of cell viability of the A549-shCtrl, A549-shPPA1-1, and A549-shPPA1-2 cell lines under glucose starvation. (B) Colony formation of A549-shCtrl, A549-shPPA1-1, and A549-shPPA1-2 cell lines under glucose-starved conditions (crystal violet staining; magnification, ×1). (C) Cell cycle analysis by flow cytometry in A549-shCtrl, A549-shPPA1-1, and A549-shPPA1-2 cells under glucose starvation. (D) Western blotting detection of the expression of proliferative proteins in PPA1-silenced A549 cells under glucose starvation. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001, compared with the shCtrl group; N=3. shPPA1-1 vs. shCtrl: p21-0h, P=0.004; CDK2-0h, P<0.001; Ki-67-0h, P<0.001; p53-0h, P=0.001; p21-24h, P=0.03; CDK2-24h, P=0.008; Ki-67-24h, P=0.003; p53-24h, P<0.001; shPPA1-2 vs. shCtrl: p21-0h, P<0.001; CDK2-0h, P<0.001; Ki-67-0h, P<0.001; p53-0h, P=0.03; p21-24h, P<0.001; CDK2-24h, P=0.007; Ki-67-24h, P=0.01; p53-24h, P=0.001. shCtrl group: empty vector control group; shPPA1-1 and shPPA1-2 groups: PPA1-silencing groups. PE-A, phycoerythrin-area; PPA1, inorganic pyrophosphatase 1.
Article Snippet: PPA1 antibody (B-8), beta-actin antibody (C4), and TP53 antibody (D0-1) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA), Ki-67 antibody was purchased from Abcam (Cambridge, UK).
Techniques: CCK-8 Assay, Staining, Cell Cycle Assay, Flow Cytometry, Western Blot, Expressing, Plasmid Preparation, Control